Series C - Inanovate
Investment Firm
Overview
Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.
Announced Date
Apr 03, 2019
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Inanovate raised $3100000 on 2019-04-03 in Series C
Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 06, 2022 |  Venture Round - Inanovate | - | 2.4M | |
| Dec 11, 2023 | Venture Round - Inanovate | - | 1.5M | |
| Jun 12, 2024 | Venture Round - Inanovate | - | 1.1M | |
| Dec 17, 2015 | Seed Round - Inanovate | - | 502.4K |
Recent Activity
There is no recent news or activity for this profile.